Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide in hereditary osteoporosis
2010-019297-32Phase 4Completed
- Sponsor
- Ville-Valtteri Välimäki
- Start
- Mar 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of teriparatide in osteoporosis, sponsored by Ville-Valtteri Välimäki. Primary endpoint: Change in lumbar spine bone mineral density. Started Mar 2010; status: completed.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2010-019297-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019297-32.